Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,119.00    40.50 (3.76%)
Bid:
1,113.50
Ask:
1,114.50
Spread: 1.00 (0.09%)
Market Cap: £3.59b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

COVID-19 Update

14 May 2020 07:00

RNS Number : 8335M
Persimmon PLC
14 May 2020
 

14 May 2020

 

Persimmon plc

("Persimmon" or "the Group")

 

COVID-19 Update

 

Persimmon is today providing a further update on its response to the COVID-19 pandemic.

 

The health, safety and wellbeing of the public and everyone who works on its sites and in its offices remains Persimmon's top priority, and the Group is continuing to adopt all UK Government and construction industry guidance on safe working procedures, as it progressively re-opens for business. In the weeks following 25 March 2020, when its construction sites were closed, the Group worked closely with its colleagues, sub-contractors and suppliers to develop and test a range of new protocols to enable work to recommence safely, in anticipation of a potential return to its sites and its sales offices in due course. It is this work that is now enabling a swift and efficient restart.

 

The ability to recommence operations swiftly has been made possible by the Group's decision not to furlough staff and to continue to pay all colleagues in full throughout the shutdown period, without recourse to Government assistance. This has retained talent directly within the business and ensured operational continuity at site level, supporting both the introduction of new safer working methods and restart activity.

 

Re-commencement of on-site sales activities

 

The Group's sales teams have continued to work effectively and efficiently to serve new and existing customers, making use of online resources, including virtual viewings and digitalised reservation processes, over recent weeks.

 

The Group is pleased to announce that, following the publication of new guidance by the UK Government which took effect from 13 May 2020, it will reopen its sales offices in England on Friday 15 May 2020.

 

All sales offices and show homes will reopen with strict new social distancing and additional hygiene measures in place, which are fully compliant with the latest UK Government guidance. Initially, sales consultations will be on a pre-booked appointment basis only.

 

Progress of construction activity

As previously announced the Group began a phased return to work on its construction sites in England and Wales on 27 April 2020. This process continues to progress smoothly and to plan. During the week beginning 4 May 2020 c. 65% of production capacity had been restored.

The Group's businesses in Scotland remain in shutdown, pending further guidance on a restart timetable from the Scottish Government.

Trading Update

In the eight weeks ended 10 May 2020 the Group secured 1,351 gross private sales reservations, with a total of 1,300 legal completions being made in the same period. Cancellation levels remain in line with historic trends.

The Group is pleased to note that, working within the bounds of social distancing restrictions, it was able to complete activity to ensure that no customers were left in a vulnerable position through this period.

David Jenkinson, CEO, said: "We support the Government's view that the housing sector has a key role to play in the UK's economic recovery. The urgent need for new homes has not been diminished by COVID-19 and the new measures announced by the Government will re-open the housing market and allow people to get moving again. Our sales colleagues can now begin to return to site but staff and customer safety remains our first priority and we have put in place new protocols and training procedures to enable them to restart operations safely.

"Persimmon decided not to access any form of Government support during the shutdown period and has maintained its commitments to its colleagues and communities in full throughout. Now, as we re-start activity, this decision is also enabling us to get back to work swiftly and safely. Persimmon is open for business and we are looking forward to welcoming customers back to site and continuing to play our part in rebuilding Britain's economy."

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the Group is Tracy Davison, Company Secretary.

For further information, please contact:

Citigate Dewe Rogerson

Simon Rigby / Kevin Smith / Jos Bieneman

Tel: +44 (0)20 7638 9571

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGPUBCAUPUGMW
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.